SUBSCRIBE

WHO prequalifies first generic hepatitis C drug

 Posted 18/08/2017

The World Health Organization (WHO) has pre-qualified the first generic drug to treat hepatitis C. The antiviral agent sofosbuvir will be manufactured at a l...

more
Biosimilar pegfilgrastim highly similar to Neul... Biosimilars/Research | Posted 18/08/2017
Biosimilars of insulin lispro Biosimilars/General | Posted 18/08/2017
Real-life data supports efficacy and safety of... Biosimilars/Research | Posted 18/08/2017
Biocad’s rituximab ‘similar biologic’ recommend... Biosimilars/News | Posted 18/08/2017
FDA to speed up review of priority generics Guidelines | Posted 18/08/2017
Generics in Greece most expensive in the EU and... Pharma News | Posted 18/08/2017
Endo removes Opana ER opioid from the market Generics/News | Posted 18/08/2017
Generics prices increase when competition decre... Generics/Research | Posted 11/08/2017
EMA adopts five product-specific bioequivalence... Guidelines | Posted 11/08/2017
FDA accepts application for Celltrion/Teva’s ri... Biosimilars/News | Posted 11/08/2017
Biosimilar trastuzumab candidate shows ‘similar... Biosimilars/Research | Posted 11/08/2017
AAM tries to block ‘unconstitutional’ drug pric... Generics/General | Posted 11/08/2017
Setback in Biocon/Mylan’s biosimilar programme... Biosimilars/General | Posted 11/08/2017
FDA user fee reauthorization bill passes US Hou... Policies & Legislation | Posted 11/08/2017
Impax launches new high-strength ADHD generics Generics/News | Posted 11/08/2017
US prescribers’ views on the naming and labelli... Biosimilars/Research | Posted 14/07/2017
Daiichi Sankyo ends deal with Coherus for etane... Pharma News | Posted 14/07/2017
Real world switching data for etanercept biosim... Biosimilars/Research | Posted 14/07/2017
FDA rejects Pfizer’s epoetin alfa biosimilar Biosimilars/News | Posted 14/07/2017
Follow-up study finds generic tacrolimus safe f... Generics/Research | Posted 14/07/2017
US states progress drug pricing legislation Policies & Legislation | Posted 14/07/2017
Biocad registers rituximab similar biotherapeut... Biosimilars/News | Posted 14/07/2017
FDA releases 37 new and revised bioequivalence... Guidelines | Posted 14/07/2017
Scientific rationale for extrapolation of cance... Biosimilars/Research | Posted 07/07/2017
EC approval for etanercept biosimilar Erelzi Biosimilars/News | Posted 07/07/2017
FDA asks for comments on reauthorization of BsUFA Guidelines | Posted 07/07/2017
Quebec hopes to save millions by tendering for... Policies & Legislation | Posted 07/07/2017
FDA rejects pegfilgrastim biosimilar from Coherus Biosimilars/News | Posted 07/07/2017
Pharmocovigilance of rituximab in Argentina Biosimilars/Research | Posted 07/07/2017
Generics in the pipeline for 2017 in the US Generics/Research | Posted 07/07/2017
FDA lists drugs without generics to increase co... Generics/General | Posted 07/07/2017
Physicians' concerns on FDA’s interchangeabilit... Guidelines | Posted 30/06/2017
EMA approval for adalimumab biosimilar Imraldi Biosimilars/News | Posted 30/06/2017
Trastuzumab biosimilar could reduce breast canc... Biosimilars/Research | Posted 30/06/2017
EMA launches new EudraVigilance system for adve... Policies & Legislation | Posted 30/06/2017
Adalimumab and infliximab biosimilars from Sand... Biosimilars/News | Posted 30/06/2017
UK introduces new law to control generic drug p... Generics/General | Posted 30/06/2017
Biosimilars of pegaspargase Biosimilars/General | Posted 30/06/2017
AAM 2017 Fall Technical Conference Conferences | Posted 30/06/2017
Biosimilars and sustainability Biosimilars/Research | Posted 23/06/2017
EC approval for rituximab biosimilar Rixathon Biosimilars/News | Posted 23/06/2017
Boehringer Ingelheim’s adalimumab biosimilar ‘e... Biosimilars/Research | Posted 23/06/2017
Baxter and Dorizoe make deal for generic inject... Generics/General | Posted 23/06/2017
Comments on switching in FDA’s interchangeabili... Guidelines | Posted 23/06/2017
US Senate revives the CREATES Act Policies & Legislation | Posted 23/06/2017
UK investigation suggests Merck broke competiti... Biosimilars/General | Posted 23/06/2017
FDA approval for generics of ADHD drug Strattera Generics/News | Posted 23/06/2017
Notice can be given before FDA approves biosimilar Policies & Legislation | Posted 16/06/2017
Comments on extrapolation in FDA’s interchangea... Guidelines | Posted 16/06/2017
more

NON-BIOLOGICAL COMPLEX DRUGS

FDA approves follow-on version of sevelamer Posted 30/06/2017

Indian generics maker Aurobindo Pharma (Aurobindo) announced on 15 June 2017...

more


Challenges in the regulation of NBCDs Non‐Biological Complex Drugs/Research | Posted 12/05/2017
Scientific and regulatory considerations for fo... Non‐Biological Complex Drugs/Research | Posted 05/05/2017
Equivalence of complex drug products Non‐Biological Complex Drugs/Reports | Posted 14/04/2017
Follow-up studies needed to ensure safety for f... Non‐Biological Complex Drugs/Research | Posted 31/03/2017
Warning letter causes delays for follow-on glat... Non‐Biological Complex Drugs/News | Posted 17/03/2017
Is the EU ready for non-biological complex drug... Non‐Biological Complex Drugs/Research | Posted 03/03/2017
Follow-on versions of glatiramer acetate in Rus... Non‐Biological Complex Drugs/News | Posted 24/02/2017
Non-biological complex drugs and pharmacopoeias Non‐Biological Complex Drugs/Research | Posted 10/02/2017
In vitro analysis of follow-on versions of seve... Non‐Biological Complex Drugs/Research | Posted 18/11/2016
Determining the bioequivalence of follow-on iro... Non‐Biological Complex Drugs/Reports | Posted 04/11/2016
FDA to set up abbreviated pathway for complex p... Non‐Biological Complex Drugs/Polices & Legislation | Posted 21/10/2016
Challenges in the assessment of ophthalmic emul... Non‐Biological Complex Drugs/Reports | Posted 07/10/2016
Cancer lab to evaluate bioequivalence of nanosi... Non‐Biological Complex Drugs/News | Posted 23/09/2016
A conference on ‘Equivalence of Complex Drug Pr... Non‐Biological Complex Drugs/News | Posted 09/09/2016
Collaboration to introduce nanotechnologies in... Non‐Biological Complex Drugs/News | Posted 26/08/2016
Iron carbohydrate follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 12/08/2016
Rigorous approach used to approve a follow-on v... Non‐Biological Complex Drugs/Research | Posted 29/07/2016
US guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 10/06/2016
Non-biological complex drugs and their follow-o... Non‐Biological Complex Drugs/Research | Posted 03/06/2016
Is a new pathway for NBCDs on the way in the US? Non‐Biological Complex Drugs/Polices & Legislation | Posted 27/05/2016
Follow-on glatiramer acetate gains European app... Non‐Biological Complex Drugs/News | Posted 13/05/2016
FDA includes follow-on versions in its new cycl... Non‐Biological Complex Drugs/Guidelines | Posted 29/04/2016
Switching between originator and follow-on iron... Non‐Biological Complex Drugs/Research | Posted 22/04/2016
Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015
more

Country Focus

All countries

Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!

Generics News Research General

more

Biosimilars News Research General

more

More editorial sections